The researchers believe this sensor test has potential in speeding up disease-specific analyses of genetic samples. George Vasmatzis, Ph.D., co-leader of Mayo’s Biomarker Discovery Program in the Center for Individualized Medicine, notes in the release that the assay could eliminate the need for bisulfite conversion of DNA, fluorescent labeling, and polymerase chain reaction (PCR). This research was done through the Mayo Illinois Alliance for Technology Based Healthcare, created in 2010 to advance research and clinical treatment options.
Image of the Month
Synthesizing and Consolidation of Mechanically-Induced Solid-State Reacted Ti50C50 Nanopowders and Subsequent Consolidations
BFI of the powders obtained after 5 h of the ball milling time
Nanotechnology and Advanced Materials Program, Energy and Building Research Center, Kuwait Institute for Scientific Research, Kuwait
NSTI Online Community